ClinicalTrials.govpublic full text
A Study of Dopamine Type 2 (D2) Receptor Occupancy Following a Single Oral Dose of OROS Paliperidone
schizophrenia, mood disorders, antipsychotic drugs, dopamine, receptor occupancy, oros paliperidone, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 912529
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.